Literature DB >> 8428947

Cell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signaling.

P Lorenz1, R Pepperkok, W Ansorge, W Pyerin.   

Abstract

Casein kinase II (CKII) is a highly conserved ubiquitous serine/threonine kinase composed of two catalytically active (alpha and/or alpha') and two regulatory (beta) subunits. It has been suspected that, among numerous other cellular functions, CKII might play a role in the control of mitogenic signaling. To test for such a role and its mechanism in intact cells, monoclonal antibodies (mAbs) were generated against CKII beta using a recombinant protein containing amino acids 20-200 of human CKII beta. The CKII beta-specific mAb with the highest reactivity, mAb IVG6 (classified as IgG1 with kappa light chains), was purified to homogeneity. It recognized a CKII beta epitope comprising the amino acids 140-156, a basic and highly conserved region. In addition, polyclonal antibodies (pAbs) were raised and made monospecific by affinity purification. pAbs-mediated quantitative immunofluorescence microscopy of human IMR-90 fibroblasts and/or Western blots of cell fractions revealed (i) CKII beta was present in exponentially growing cells at a 2-3-fold higher level than in quiescent cells, (ii) CKII beta was localized predominantly in the nucleus of cells (3-15-fold cytoplasmic level depending on cellular state and assay used), and (iii) the nuclear/cytoplasmic ratio of CKII beta was higher by a factor of 2 in exponentially growing cells. Consequently, mitogenic stimulation of quiescent cells by fetal calf serum doubled the nuclear/cytoplasmic ratio of CKII beta. The increase occurred within the 1st h of stimulation. The translocation of CKII beta into the nucleus was inhibited when mAb IVG6 was injected into the cytoplasm at the time of mitogenic stimulation. This microinjection also significantly inhibited the cell proliferation. The data imply that cytoplasmic CKII participates in the transmission of mitogenic signals by translocation into the nucleus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428947

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis.

Authors:  J Roig; A Krehan; D Colomer; W Pyerin; E Itarte; M Plana
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  BTF3 is a potential new substrate of protein kinase CK2.

Authors:  S Grein; W Pyerin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Searching interaction partners of protein kinase CK2beta subunit by two-hybrid screening.

Authors:  S Grein; K Raymond; C Cochet; W Pyerin; E M Chambaz; O Filhol
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Intermolecular contact sites in protein kinase CK2.

Authors:  A Krehan; W Pyerin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  Antisense expression of the CK2 alpha-subunit gene in Arabidopsis. Effects on light-regulated gene expression and plant growth.

Authors:  Y Lee; A M Lloyd; S J Roux
Journal:  Plant Physiol       Date:  1999-03       Impact factor: 8.340

Review 7.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

8.  CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

Authors:  Judit Pallares; David Llobet; Maria Santacana; Nuria Eritja; Ana Velasco; Dolors Cuevas; Susana Lopez; Victor Palomar-Asenjo; Andree Yeramian; Xavier Dolcet; Xavier Matias-Guiu
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

9.  Evidence for regulation of mitotic progression through temporal phosphorylation and dephosphorylation of CK2alpha.

Authors:  Nicole A St-Denis; D Richard Derksen; David W Litchfield
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

10.  Predominance of CK2α over CK2α' in the mammalian brain.

Authors:  Ilaria Ceglia; Marc Flajolet; Heike Rebholz
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.